Literature DB >> 28447327

Uptake of 123I-metaiodobenzylguanidine by gastrointestinal stromal tumor.

Patommatat Bhanthumkomol1,2, Susumu Hijioka3, Nobumasa Mizuno2, Takamichi Kuwahara2, Nozomi Okuno2, Ayako Ito2, Tsutomu Tanaka4, Makoto Ishihara4, Yutaka Hirayama4, Sachiyo Onishi4, Yasumasa Niwa4, Masahiro Tajika4, Yuichi Ito5, Eiichi Sasaki6, Yoshitaka Inaba7, Yasuhiro Shimizu5, Yasushi Yatabe6, Kazuo Hara2.   

Abstract

A 52-year-old woman was admitted with a large intraabdominal mass. 123I- metaiodobenzylguanidine (123I-MIBG) scintigraphy revealed considerable 123I-MIBG accumulation by the mass that was compatible with a diagnosis of paraganglioma. However, a spindle cell tumor that was identified using endoscopic ultrasound-guided fine needle aspiration before surgery was positive for CD117. The surgically resected mass was confirmed as a gastrointestinal stromal tumor (GIST). Although the mechanism of 123I-MIBG uptake by GIST has not been elucidated, GIST should be included in the differential diagnosis of intra-abdominal tumor with 123I-MIBG uptake.

Entities:  

Keywords:  Gastrointestinal stromal tumor; Metaiodobenzylguanidine; Paraganglioma; Scintigraphy

Mesh:

Substances:

Year:  2017        PMID: 28447327     DOI: 10.1007/s12328-017-0743-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  20 in total

1.  Aberrant I-123 MIBG uptake in a gastrointestinal stromal tumour.

Authors:  David van Dellen; Otilia Maria Mitu-Pretorian; Titus Augustine
Journal:  Updates Surg       Date:  2012-01-10

2.  Unusually increased metaiodobenzylguanidine uptake in a gastrointestinal stromal tumor of the stomach.

Authors:  Kazuki Fukuchi; Makoto Suzuki; Shinsuke Sato; Jouji Iseki
Journal:  Ann Nucl Med       Date:  2012-05-29       Impact factor: 2.668

3.  False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma.

Authors:  T Rainis; S Ben-Haim; G Dickstein
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

4.  An [123 I]MIBG-positive malignant lymphoma involving the adrenal gland with hypercatecholaminaemia.

Authors:  H Kume; S Nishimura; S Teramoto; A Niimi; K Tomita; T Kitamura
Journal:  Clin Radiol       Date:  2007-11-26       Impact factor: 2.350

5.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

Authors:  L G Kindblom; H E Remotti; F Aldenborg; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

6.  I-123 MIBG uptake in a gastrointestinal stromal tumor (GIST).

Authors:  Kottekkattu K Balan; Luke I Sonoda; Davina Pawaroo
Journal:  Clin Nucl Med       Date:  2010-03       Impact factor: 7.794

7.  False-positive radio-iodinated metaiodobenzylguanidine (123I-MIBG) accumulation in a mast cell-infiltrated infantile haemangioma.

Authors:  C Rottenburger; E Juettner; A C Harttrampf; M Hentschel; U Kontny; J Roessler
Journal:  Br J Radiol       Date:  2010-08       Impact factor: 3.039

8.  False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma.

Authors:  Y Inoue; M Akahane; T Kitazawa; H Ijichi; S Obi; K Yoshikawa; K Ohtomo; M Omata
Journal:  Br J Radiol       Date:  2002-06       Impact factor: 3.039

9.  Summary, conclusions, and future directions of [131I]metaiodobenzylguanidine therapy in the treatment of neural crest tumors.

Authors:  B Shapiro
Journal:  J Nucl Biol Med       Date:  1991 Oct-Dec

10.  False Positive Radioiodinated Metaiodobenzylguanidine ((123)I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor.

Authors:  Hee Soo Jung; Seok Jun Moon; Yun Mi Kim; Hye Rim Kang; Seok Mo Lee; Soo Jin Jung; Seok Jin Choi; Tae Kyoon Kim; Min Jeong Kwon; Jeong Hyun Park; Soon Hee Lee
Journal:  Case Rep Oncol Med       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.